Uptake of [3H]-adrenaline by freshly isolated rat hepatocytes: Putative involvement of P-glycoprotein

Journal of Autonomic Pharmacology

Volumn 18, Issue 1, 1998, Pages 57-64

  Martel, F ^a,b   Calhau, C ^b   Martins, M J ^b   Azevedo, I ^a  

^a Institute of Pharmacology and Therapeutics

^b Inst of Pharmacol and Therapeutics   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; ADRENALIN; CYCLOSPORIN A; DIMETHYL SULFOXIDE; VERAPAMIL; CALCIUM CHANNEL BLOCKING AGENT; CATECHOLAMINE; GLYCOPROTEIN P; TRITIUM;

ANIMAL CELL; ARTICLE; CATECHOLAMINE RELEASE; CELL ISOLATION; DIFFUSION; DRUG DISTRIBUTION; DRUG EFFECT; LIVER CELL; LIVER METABOLISM; MEMBRANE BINDING; NONHUMAN; RAT; ANIMAL; CELL CULTURE; COMPARATIVE STUDY; CULTURE MEDIUM; CYTOLOGY; DRUG ANTAGONISM; LIVER; MALE; METABOLISM; PH; WISTAR RAT;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; CALCIUM CHANNEL BLOCKERS; CATECHOLAMINES; CELLS, CULTURED; CULTURE MEDIA; EPINEPHRINE; HYDROGEN-ION CONCENTRATION; LIVER; MALE; P-GLYCOPROTEIN; RATS; RATS, WISTAR; TRITIUM; VERAPAMIL;

EID: 0031595948     PISSN: 01441795     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2680.1998.1810057.x     Document Type: Article

References (42)

1. AXELROD, J. (1959). Metabolism of epinephrine and other sympathomimetic amines. Physiol. Rev., 39, 751-776.
2. AXELROD, J. (1966). Methylation reactions in the formation and metabolism of catecholamines and other biogenic amines. Pharmacol. Rev., 18, 95-113.
3. BLASHKO, H. (1952). Amine oxidase and amine metabolism. Pharmacol. Rev., 4, 415-453.
4. BRADFORD, M. (1976). A rapid method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
5. BREIDERT, T., SPITZENBERGER, F., GRNDEMANN, D. & SCHMIG, E. (1997). The organic cation transporter OCT1 accepts biogenic amines as substrates. J. Anton. Pharmacol., 17, 223.
6. CHEKG, Y. & PRUSOFF, W.H. (1973). Relationship between the inhibition constants (kj) and the concentration which causes 50% inhibition of enzymatic reaction. Biochem. Pharmacol., 22, 403-411.
7. DANIELS, A.J. & REINHARD, F.J., JR. (1988). Energy-driven uptake of the neurotoxin l-methyl-4-phenylpyridinium into chromaffin granules via the catecholamine transporter.J. Biol. Chem., 263, 5034-5036.
8. EISENHOFER, G., RUNDQUIST, B-, ANEMAN, A., FRIBERG, P., DAKAK, N., KOPIN, I.J., JACOBS, M.-C. & LENDERS, J.W.M. (1995). Regional release and removal of catecholamines and extraneuronal metabolism to metanephrines. J. Clin. Endocrin. Metab., 80, 3009-3017.
9. GOTTESMAN, M.M. & PASTAN, I. (1993). Biochemistry of multidrug resistance mediated by the muhidrug transporter. Ann. Rev. Biochem., 62, 385-427.
10. GRAEFE, K.-H., STEFANO, F.J.E. & LANCER, S.Z. (1973). Preferential metabolism of 3H-(-)-noradrenaline through the deaminated glycol in the rat vas deferens. Biochem. Pharmacol., 22, 1147-1160.
11. GRÜNDEMANN, D., GORBOULEV, V., GAMBARYAN, S., VEYHL, M. & KOEPSELL, H. (1994). Drug excretion mediated by a new prototype of polyspecific transporter. Nature, 372,549-552.
12. MERITING, G. & LABROSSE, E.H. (1962). Biliary and urinary excretion of metabolites of 7-3H-epinephrine in the rat. J. Biol. Chem., 237, 2291-2295.
13. HUNTER, J., JEPSON, M.A., TSURUO, T., SIMMONS, N.L. & HIRST, B.H. (1993). Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. Kinetics of vinblastine secretion and interaction with modulators. ;. Bio!. Chem., 268, 14991-14997.
14. ICHIKAWA, M., YOSHIMURA, A., SUMIZAWA, T., SHUDO, N., KITWAZURU, Y., FURUKAWA, T. & AKIYAMA, S.-I. (1991). Interaction of organic chemicals with P-glycoprotein in the adrenal gland, kidney, and a multidrug-resistant KB cell.J. Biol. Chem., 266, 903-908.
15. JAVITCH, J.A. & SNYDER, s.H. (1985). Uptake of MPPby dopamine neurons explains selectivity of parkinsonism-inducing neurotoxin, MPTP. Eur. ]. Pharmacol., 106, 455-t56.
16. KAMIMOTO, Y., GATMAITAN, Z., HSU, J. &: ARIAS, I.M. (1989). The function of Gpl70, the multidrug resistance gene product, in rat liver canalicular membrane vesicles.J. Biol. Chem., 264, 11693-11698.
17. KEPPLER, D. & ARIAS, I.M. (1997). Introduction: transport across the hepatocyte canalicular membrane. FASEB]., 11, 15-18.
18. KLAASSEN, C. & WATKINS, J., Ill (1984). Mechanisms of bile formation, hepatic uptake, and biliary excretion. Pharmacol. Rev., 36, 1-67.
19. KOPIN, I.J. (1985). Catecholamine metabolism: basic aspects and clinical significance. Pharmacol. Rev., 37, 333-364.
20. + exchanger of renal brush-border membrane vesicles. Am. ]. Physiol., 258, F597-F605.
21. LIGHTMAN, S.L. HEMS, D.A. (1973). Metabolism of adrenaline in the isolated perfused liver of the rat. Biachem. Pharmacol., 22, 2419-2423.
22. 3H]-(-(noradrenaline in the perfused rat liver. J. Anton. Pharmacol., 15, 309-319.
23. MARTEL, F., AZEVEDO, I. &: OSSWALD, w. (1993). Uptake and metabolism of 3H-adrenaline and 3H-noradrenaline by isolated hepatocytes and liver slices of the rat. NaunynSchmiedeberg's Arch. Pharmacol., 348, 350-357.
24. MARTEL, F., AZEVEDO, I. &: OSSWALD, W. (1994). Uptake of 3H-catecholamines by rat liver cells occurs mainly through a system which is distinct from uptakei or uptakea. Naiinyn-Schmiedeberg's Arch. Pharmacol., 350, 130-135.
25. MARTEL, F., MARTINS, M.J. Sc AZEVEDO, I. (1996b). Inward transport of 3H-MPPin freshly isolated rat hepatocytes: evidence for interaction with catecholamines. NannynScbmicdeberg's Arch. Pharmacol., 354, 305-311.
26. MARTEL, F., MARTIN'S, M.J., HIPOLITO-REIS, C. & AZEVEDO, 1. (1996c). Inward transport of 3H-MPP in isolated rat hepatocytes: putative involvement of a P-glycoprotein transporter. Br. J. Pharmacol., 119, 1519-1524.
27. MARTEL, F., RUSS, H., AZEVEDO, I. & SCHÖ.MIG, E. (1995). Uptake and accumulation of N-methyl-4-phenylpyridinium (MPP) by rat hepatocytes. Br. J. Pharmacol., 114 (Suppl.), 262P.
28. MARTEL, F., VETTER, T., RUSS, H., GRÜNDEMANN, D., AZEVEDO, L, KOEPSELL, H. & SCHÖMIG, E. (1996a). Transport of small organic cations in the rat liver. The role of the organic cation transporter OCT1. Naunyn-Schmiedeberg's Arch. Pharmacol., 354, 320-326.
29. MEIJER, D., MOL, W., MULLER, M. & KURZ, G. (1990). Carriermediated transport in the hepatic distribution and elimination of drugs, with special reference to the category of organic cations.J. Pharmacokinet. Biopharm., 18, 35-70.
30. MELA.MED, E., ROSENTHAL, J., COHEN, O., GLOBUS, M. &: UZZAN, A. (1985). Dopamine but not norepinephrine or serotonin uptake inhibitors protect mice against neurotoxicity of MPTP. Enr. J. Pharmacol., 116, 179-181.
31. OUDE ELFERINK, R.P.J., MEIJER, D.K.F., KUIPERS, F., JANSEN, P.L.M., GROEN, A.K. & GROOTHIUS, G.M.M. (1995). Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport. Biochim. Biophys. Ada, 1241, 215-268.
32. PILEBLAD, E. & CARLSSON, A. (1985). Catecholamine-uptake inhibitors prevent the neurotoxicity of l-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse brain. Netiropharmacology, 24, 689-692.
33. RUSS, H., GLIESE, M., SOXNA, J. &: SCHÖMIG, E. (1992). The extraneuronal transport mechanism for noradrenaline (uptakei) avidly transports l-methyI-4-phenyIpyridinium (MPP). Naunyn-Schmiedeberg's Arch. Pharmacol., 346, 158-165.
34. RUSS, H., STAUBT, K., MARTEL, F., GLIESE, M. &: SCHÖMIG, E. (1996). The extraneuronal transporter for monoamine transmitters exists in cells derived from human central nervous system glia. Etir. J. Nenrosci., 8, 1256-1264.
35. SALT, PJ. (1972). Inhibition of noradrenaline uptake in the isolated heart by steroids, clonidine and methoxylated phenylethylamines. Enr. J. Pharmacol., 20, 329-340.
36. SEGEL, l.n. (1975). Enzyme Kinetics: Behaviour and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems. John Wiley, New York.
37. SOKOL, P.P., HOLOHAN, P.D. & ROSS, C.R. (1987). The neurotoxins l-methyl-4-phenylpyridinium and l-methyl-4phenyl-l,2,3,6-tetrahydropyridine are substrates for the organic cation transporter in renal brush border membrane vesicles. J. Pharmacol. Exp. Ther., 22, 152-157.
38. STAUDT, K., RUSS, H., GLIESE, M. Se SCHÖMIG, E. (1993). The extraneuronal noradrenaline carrier (uptake2 exists in the central nervous system (CNS). Naunyn-Schmiedeberg's Arch. Pharmacol., 347, R118.
39. STEINBERG, P., ACEVEDO, C, MASANA, M.I. &: RUBIO, M.C. (1988). Uptake and metabolism of 3H-(±)-noradrenaIine in the isolated perfused rat liver. Naunyn-Scbmiedeberg's Arch. Pharmacol., 337, 392-396.
40. TSUJI, A., TAMAI, I., SAKATA, A., TEKDA, Y. & TERASAKI, T. (1993). Restricted transport of cyclosporin A across the blood-brain barrier by a multidrug transporter, P-glycoprotein. Biochem. Pharmacol., 46, 1096-1099.
41. VORE, M. (1994). Regulation of drug conjugate processing by hepatocellular transport systems. In: Conjugation-Deconjugation Reactions in Drug Metabolism and Toxicity, Handb. Exp. Pharmacol., Vol. 112, pp. 311-338. Ed. F.C. Kauffman. Springer-Verlag, Berlin.
42. ZIMON, R.P., TYCE, G.M., ROCK, E.V., SHEPS, S.G. 8c OWEN, C.A., JR (1967). Effect of monoamine oxidase inhibition on biliary excretion of metabolites of norepinephrine by isolated rat liver.J. Pharmacol. Exp. Ther., 157, 89-95.